Fingerprint Dive into the research topics of 'Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically